Biozeus

OURTEAM

The selection of commercially viable drug candidates and advancing their development
toward worldwide markets is a complex and challenging task that requires people with a broad
range of different qualifications and drug development know-how.

BUILT ONA STRONG
FOUNDATION

  • Professionals with scientific, medical and management experience in the broad range of disciplines required to take candidate drugs from early-stage evaluation through preclinical and clinical development to commercial success.
  • Leadership with a record of entrepreneurial business success and deep management experience in the health care, pharmaceutical and biotechnology industries.
  • A worldwide network of team members who bring to Biozeus specific drug development know-how and decades of experience in commercial drug development.
 

Izabella Harumi Abe

Administrative analyst
 

Martin Bonamino

Advisor
 

Perla Borges

Project Analyst
 

Diego Allonso

Project Analyst
 

Iron de Paula Jr

Project Analyst
 

Caio França

Project Analyst
 

Paulo Lacativa

Project Manager
 

GERD BODE

Toxicology Advisor
 

BERT HO

CMC specialist
 

Pedro Palmeira

Board member
 

Viviane Ribeiro

Financial Director
 

Gerhard Gross

Development Leader
 

João Paulo Poiares Baptista

Chairman of the Board
 

Martin Emilio Munk

Preclinical drug development specialist
 

Thomas Gerlach

Director
 

Bryant E. Fong

Board member
 

Luis Eduardo Caroli

CEO Director
 

Timothy Tankosic

Advisor
 

Jorge Ávila

Board member
 

Pam Hirtzer

CMC specialist